The S&P 500 ended higher on Thursday, snapping a five-session losing streak, as investors interpreted data showing a rise in weekly jobless claims as a sign the pace of interest rate hikes could soon slow. Wall Street’s main indexes had come under pressure in recent days, with the S&P 500 shedding 3.6% since the beginning … Read more
The U.S. on Wednesday authorized Pfizer Inc‘s oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus and a potentially important tool in the fight against the fast spreading Omicron variant. Data from Pfizer’s clinical trial showed its antiviral regimen, Paxlovid, was 90% effective in … Read more
A total of 2,660 healthy adult participants aged 18 and older will be randomly assigned to receive PF-07321332/ritonavir or placebo. (Representative Image) Pfizer Inc has started a large study testing its investigational oral antiviral drug to prevent Covid-19 infection among those already exposed to the virus. The Phase 2/3 trial by Pfizer in of the … Read more
The U.S. government said on Wednesday it plans to make COVID-19 vaccine booster shots widely available to all Americans starting on Sept. 20 as infections rise from the Delta variant of the coronavirus. The White House is prepared to offer a third booster shot starting on that date to all Americans who completed their initial … Read more
U.S. pharmaceutical maker Pfizer Inc will seek authorization from Mexico’s health regulator for use of its COVID-19 vaccine in children aged 12-15, Mexican Foreign Minister Marcelo Ebrard said on Wednesday. “Pfizer will submit the request for authorization from Cofepris for the vaccine, applicable to minors between 12 and 15 years old, in the next few … Read more
OTTAWA, – Canadian Prime Minister Justin Trudeau will announce on Tuesday that the government has reached an agreement with Moderna Inc to receive the first deliveries of its COVID-19 vaccine within 48 hours of regulatory approval, the CBC said. The Canadian Broadcasting Corp gave no further details. Moderna’s vaccine is currently under review by Canada’s … Read more
Gold slumped more than 5% on Monday as news of the first successful late-stage COVID-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets. Spot gold was down 4.9% at $1,854.44 per ounce by 10:11 p.m. IST, while US gold futures slid 4.9% to $1,855.30. Spot prices beat a sharp retreat … Read more
Moderna Inc’s vaccine against COVID-19 could be ready for widespread use by the end of this year, U.S. and company officials said on Monday, after the drugmaker announced the start of a 30,000-subject trial to demonstrate it is safe and effective, the final hurdle prior to regulatory approval. The trial is the first such late-stage … Read more